Gene expression profiles in alveolar macrophages induced by lipopolysaccharide in humans

Molecular Medicine

Volumn 18, Issue 9, 2012, Pages 1303-1311

  Reynier, Frederic ^a   de Vos, Alex F ^b   Hoogerwerf, Jacobien J ^b   Bresser, Paul ^b   van der Zee, Jaring S ^b   Paye, Malick ^a   Pachot, Alexandre ^a   Mougin, Bruno ^a   van der Poll, Tom ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CLUSTER ANALYSIS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MALE; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TRANSCRIPTOME; TUMOR NECROSIS FACTORS; YOUNG ADULT;

EID: 84870353204     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2012.00230     Document Type: Article

References (27)

1. Beutler B, Rietschel ET. (2003) Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 2:169-76.
2. Rylander R. (2002) Endotoxin in the environment: exposure and effects. J. Endotoxin. Res. 8:241-52.
3. Michel O. (2003) Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions. J. Endotoxin. Res. 9:293-300.
4. Mizgerd JP. (2008) Acute lower respiratory tract infection. N. Engl. J. Med. 358:716-27.
5. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S. (2008) Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe. 3:352-63.
6. O'Grady NP, et al. (2001) Local inflammatory responses following bronchial endotoxin instillation in humans. Am. J. Respir. Crit. Care Med. 163:1591-8.
7. Nick JA, et al. (2004) Recombinant human activated protein C reduces human endotoxininduced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood. 104:3878-85.
8. van der Poll T, Levi M, Nick JA, Abraham E. (2005) Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans. Am. J. Respir. Crit. Care Med. 171:1125-8.
9. Hoogerwerf JJ, et al. (2008) Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans. Am. J. Respir. Crit. Care Med. 178:34-41.
10. Hoogerwerf JJ, et al. (2009) Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide. Crit. Care Med. 37:619-25.
11. Irizarry RA, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 4:249-64.
12. Bolstad BM, Irizarry RA, Astrand M, Speed TP. (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 19:185-93.
13. Smyth GK. (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:Article3.
14. Calvano SE, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature. 437:1032-7.
15. Talwar S, et al. (2006) Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiol. Genomics. 25:203-15.
16. Haimovich B, et al. (2010) A novel model of common Toll-like receptor 4-and injury-induced transcriptional themes in human leukocytes. Crit. Care. 14:R177.
17. Kotz KT, et al. Clinical microfluidics for neutrophil genomics and proteomics. Nat. Med. 16:1042-7.
18. Maris NA, et al. (2005) Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers. Thromb. Haemost. 93:1036-40.
19. Maris NA, et al. (2005) Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am. J. Respir. Crit. Care Med. 172:878-84.
20. Coldren CD, et al. (2006) Functional and genomic changes induced by alveolar transmigration in human neutrophils. Am. J. Physiol. Lung Cell Mol. Physiol. 291:L1267-76.
21. de Torre C, Ying SX, Munson PJ, Meduri GU, Suffredini AF. (2006) Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics. 6:3949-57.
22. Opitz B, van Laak V, Eitel J, Suttorp N. (2010) Innate immune recognition in infectious and noninfectious diseases of the lung. Am. J. Respir. Crit. Care Med. 181:1294-309.
23. Winkles JA. (2008) The TWEAK-Fn14 cytokinereceptor axis: discovery, biology and therapeutic targeting. Nat. Rev. Drug Discov. 7:411-25.
24. Chacon MR, et al. (2006) Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue: relationship with other inflammatory cytokines in obesity. Cytokine. 33:129-37.
25. Kim SH, et al. (2004) TWEAK can induce proinflammatory cytokines and matrix metalloproteinase-9 in macrophages. Circ. J. 68:396-9.
26. Xu H, et al. (2004) TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF. Biochem. Biophys. Res. Commun. 318:422-7.
27. van der Poll T, et al. (1995) Endotoxin induces downregulation of tumor necrosis factor receptors on circulating monocytes and granulocytes in humans. Blood. 86:2754-9.